The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, November 12, 2019
RMJ Holdings announced its first drug candidate, RMJH-111B for essential hypertension, is being prepared for Phase 3 development.
read more
Monday, November 11, 2019
GW Pharmaceuticals announced EPIDYOLEX oral solution and Sativex have been recommended by the UK’s NICE to receive routine reimbursement from NHS ...
read more
Monday, November 11, 2019
The FDA has granted approval to Reblozyl for the treatment of anemia in adult patients with beta thalassemia who require regular RBC transfusions.
read more
Friday, November 08, 2019
SQZ Biotechnologies and AskBio announced a research collaboration to create TACs containing AAV components to solve the barrier to treatment posed by ...
read more
Thursday, November 07, 2019
Compugen announced The EPO has granted a new patent covering the composition of matter and use of COM902.
read more
Thursday, November 07, 2019
TransThera Biosciences received Orphan Drug Designation from the FDA for TT-00420, a clinical stage investigational drug, for the treatment of ...
read more
Thursday, November 07, 2019
EIP Pharma announced the REVERSE-SD study of neflamapimod in early-stage Alzheimer's disease met its secondary objectives of target engagement and ...
read more
Wednesday, November 06, 2019
Regeneron provided an update on the ongoing Phase 3 development program evaluating Libtayo, a PD-1 inhibitor, as monotherapy and combination therapy ...
read more
Wednesday, November 06, 2019
Regeneron announced a research collaboration and licensing agreement focused on the development of new oncolytic virus-based treatments for cancer.
read more
Tuesday, November 05, 2019
Cartesian Therapeutics has initiated a Phase 1/2 clinical trial of its lead CAR-T candidate, Descartes-08, in patients with generalized myasthenia ...
read more
Tuesday, November 05, 2019
Inovio announced positive interim results from the Phase 2 study of newly diagnosed GBM combining INO-5401 and INO-9012 in combination with Libtayo.
read more
Monday, November 04, 2019
Americans deserve to have confidence in the quality of drugs the FDA regulates – from the prescription medicines they take to the OTC products they ...
read more
Monday, November 04, 2019
Halozyme announced the HALO-301 Phase 3 clinical study evaluating investigational new drug PEGPH20 failed to reach the primary endpoint of overall ...
read more
Friday, November 01, 2019
Rutgers has been designated as a NIH's REACH program to speed up the commercialization of biomedical discoveries into viable diagnostics.
read more
Friday, November 01, 2019
Amgen has entered into a strategic collaboration with BeiGene that will accelerate Amgen's plans to expand its oncology presence in China.
read more